Polymorphism in the TNF-α(-863) locus associated with reduced risk of primary open angle glaucoma

Molecular Vision

Volumn 18, Issue , 2012, Pages 779-785

  Wang, Chun Yuan ^a,b,c,d,e   Shen, Ying Cheng ^a   Wei, Li Chen ^a   Lin, Keng Hung ^a   Feng, Shih Chao ^a   Yang, Yi Yin ^b   Chiu, Chun Hung ^b   Tsai, Hin Yeung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^e CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTECTION; RISK REDUCTION; SEQUENCE ANALYSIS; TRABECULECTOMY; TUMOR NECROSIS FACTOR ALPHA GENE;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GLAUCOMA, OPEN-ANGLE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; TAIWAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859465562     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90:262-7.
2. Wiggs JL, Ynagi G, Maselli M, Auguste J, Del Bono E, Olson LM, Haines JL. A genomewide scan identifies novel earlyonset primary open-angle loci on 9q22 and 20p12. Am J Hum Genet 2004; 74:1314-20.
3. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R. Identification of a gene that causes primary open angle glaucoma. Science 1997; 275:668-70.
4. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Heon E, Krupin T, Ritch R, Kreutzer D, Crick RP, Sarfarazi M. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002; 295:1077-9.
5. Hauser MA, Allingham RR, Linkroum K, Wang J, LaRocque-Abramson K, Figueiredo D, Santiago-Turla C, del Bono EA, Haines JL, Pericak-Vance MA, Wiggs JL. Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2006; 47:2542-6.
6. Monemi S, Spaeth G, Dasilva A, Popinchalk S, Ilitchev E, Liebmann J, Ritch R, Heon E, Crick RP, Child A, Sarfarazi M. Identification of a novel adult-onset primary open angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 2005; 14:725-33.
7. Stoilov I, Akarsu AN, Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 1997; 6:641-7.
8. López-Garrido MP, Sanchez-Sanchez F, Lopez-Martinez F, Aroca-Aguilar JD, Blanco-Marchite C, Coca-Prados M, Escribano J. Heterozygous CYP1B1 gene mutations in Spanish patients with primary open-angle glaucoma. Mol Vis 2006; 12:748-55.
9. Khan AO. Genetics of primary glaucoma. Curr Opin Ophthalmol 2011; 22:347-55.
10. Aung T, Ocaka L, Ebenezer ND, Morris AG, Brice G, Child AH, Hitchings RA, Lehmann OJ, Bhattacharya SS. Investigating the association between OPA1 polymorphisms and glaucoma: comparison between normal tension and high tension primary open angle glaucoma. Hum Genet 2002; 110:513-4.
11. Ressiniotis T, Griffiths PG, Birch M, Keers S, Chinnery PF. The role of apolipoprotein E gene polymorphisms in primary open-angle glaucoma. Arch Ophthalmol 2004; 122:258-61.
12. Lin HJ, Tsai FJ, Hung P, Chen WC, Chen HY, Fan SS, Tsai SW. Association of E-cadherin gene 3'-UTR C/T polymorphism with primary open angle glaucoma. Ophthalmic Res 2006; 38:44-8.
13. Pasutto F, Matsumoto T, Mardin CY, Sticht H, Brandstätter JH, Michels-Rautenstrauss K. Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma. Am J Hum Genet 2009; 85:447-56.
14. Acharya M, Mookherjee S, Bhattacharjee A, Thakur SK, Bandyopadhyay AK, Sen A, Chakrabarti S, Ray K. Evaluation of the OPTC gene in primary open angle glaucoma: functional significance of a silent change. BMC Mol Biol 2007; 8:21.
15. Wax MB, Yang J, Tezel G. Serum autoantibodies in patients with glaucoma. J Glaucoma 2001; 10:S22-4.
16. Wax M, Yang J, Tezel G. Autoantibodies in glaucoma. Curr Eye Res 2002; 25:113-6.
17. Tezel G, Wax MB. The immune system and glaucoma. Curr Opin Ophthalmol 2004; 15:80-4.
18. Mookherjee S, Banerjee D, Chakraborty S, Banerjee A, Mukhopadhyay I, Sen A, Ray K. Association of IL-1A and IL-1B loci with primary angle glaucoma. BMC Med Genet 2010; 11:99.
19. Wax MB, Tezel G, Saito I, Gupta RS, Harley JB, Li Z, Romano C. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 1998; 125:145-57.
20. Tezel G, Seigel GM, Wax MB. Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci 1998; 39:2277-87.
21. Tezel G, Li LY, Patil RV, Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2001; 42:1787-94.
22. Tezel G, Yang J, Wax MB. Heat shock proteins, immunity and glaucoma. Brain Res Bull 2004; 62:473-80.
23. Zhou X, Li F, Kong L, Tomita H, Li C, Kao W. Involvement of inflammation, degradation and apoptosis in a mouse model of glaucoma. J Biol Chem 2005; 280:31240-8.
24. Yano T, Yamada K, Kimura A, Takeshita T, Minohara M, Kira JI, Senju S, Nishimura Y, Tanihara H. Autoimmunity against neurofilament protein and its possible association with HLADRB1* 1502 allele in glaucoma. Immunol Lett 2005; 100:164-9.
25. Ramos EM, Lin MT, Larson EB, Maezawa I, Tseng LH, Edwards KL, Schellenberg GD, Hansen JA, Kukull WA, Jin LW. Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. Arch Neurol 2006; 63:1165-9.
26. Ma SL, Tang NLS. Association between tumor necrosis factor-α promoter polymorphism and Alzheimer's disease. Neurology 2004; 62:307-9.
27. McGeer EG, McGeer PL. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis 2010; 19:355-61.
28. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF, Ransom NL, Tahzib NG, Reitsamer HA, Levkovitch-Verbin H, Quigley HA, Zack DJ. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 2002; 43:1077-87.
29. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci 2003; 8:s1140-56.Review
30. Tamura H, Kawakami H, Kanamoto T, Kato T, Yokoyama T, Sasaki K, Izumi Y, Matsumoto M, Mishima HK. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci 2006; 246:79-83.
31. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and. Prog Retin Eye Res 2006; 25:490-513.
32. Balaiya S, Edwards J, Tillis T, Khetpal V, Chalam KV. Tumor necrosis factor-alpha (TNF-α) levels in aqueous humor of primary open angle glaucoma. Clin Ophthalmol 2011; 5:553-6.
33. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, She H, Michaud N, Hafezi-Moghadam A, Miller JW, Benowitz LI. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 2006; 26:12633-41.
34. Funayama T, Ishikawa K, Ohtake Y, Tanino T, Kurosaka D, Kimura I, Suzuki K, Ideta H, Nakamoto K, Yasuda N, Fujimaki T, Murakami A, Asaoka R, Hotta Y, Tanihara H, Kanamoto T, Mishima H, Fukuchi T, Abe H, Iwata T, Shimada N, Kudoh J, Shimizu N, Mashima Y. Variants in optineurin gene and their association with tumor necrosis factor-alpha polymorphisms in Japanese patients with glaucoma. Invest Ophthalmol Vis Sci 2004; 45:4359-67.
35. Lin HJ, Tsai FJ, Chen WC, Shi YR, Hsu Y, Tsai SW. Association of tumor necrosis factor alpha -308 gene polymorphism with primary open-angle glaucoma in Chinese. Eye (Lond) 2003; 17:31-4.
36. Tekeli O, Turacli ME, Egin Y, Akar N, Elhan AH. Tumor necrosis factor alpha-308 gene polymorphism and pseudoexfoliation glaucoma. Mol Vis 2008; 14:1815-8.
37. Mossböck G, Renner W, El-Shabrawi Y, Faschinger C, Schmut O, Wedrich A, Zimmermann C, Weger M. TNF-alpha-308 G/A and -238 G /A polymorphisms are not major risk factors in Caucasian patients with exfoliation glaucoma. Mol Vis 2009; 15:518-22.
38. Razeghinejad MR, Rahat F, Kamali-Sarvestani E. Association of TNFA-308 G/A and TNFRI +36 A/G gene polymorphisms with glaucoma. Ophthalmic Res 2009; 42:118-24.
39. Khan MI, Micheal S, Rana N, Akhtar F, den Hollander AI, Ahmed A, Qamar R. Association of tumor necrosis factor alpha gene polymorphism G-308A with pseudoexfoliative glaucoma in the Pakistani population. Mol Vis 2009; 15:2861-7.
40. Anderson DR. Automated static perimetry. St. Louis: Mosbyyear Book; 1992: p12.
41. Fanning GC, Bunce M, Black CM, Welsh KI. Polymerase chain reaction haplotyping using 3' mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. Tissue Antigens 1997; 50:23-31.
42. Grutters JC, Sato H, Pantelidis P, Lagan AL, McGrath DS, Lammers JW, van den Bosch JM, Wells AU, du Bois RM, Welsh KI. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002; 165:1119-24.
43. Shohami E, Ginis I, Hallenbeck JM. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev 1999; 10:119-30.
44. Yan X, Tezel G, Wax MB, Edward DP. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmol 2000; 118:666-73.
45. Tsukada N, Miyagi K. Tumor necrosis factor and IL-1 in CSF and sera of patients with multiple sclerosis. J Neurol Sci 1991; 104:230-4.
46. Yuan L, Neufeld AH. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000; 32:42-50.
47. Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 2001; 64:523-32.
48. Lilienbaum A, Israel A. From calcium to NF-kappa B signaling pathways in neurons. Mol Cell Biol 2003; 23:2680-98.
49. Kassiotis G, Kollias G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med 2001; 193:427-34.
50. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by NMethyl-D-aspartate receptor activation: Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinasedependent NF-kappa B pathway. J Biol Chem 2004; 279:32869-81.
51. Botchkina GI, Geimonen E, Bilof ML, Villarreal O, Tracey KJ. Loss of NF-KappaB activity during cerebral ischemia and TNF cytotoxicity. Mol Med 1999; 5:372-81.
52. Tezel G, Yang X. Comparative gene array analysis of TNF alpha-induced MAPK and NF-kappaB signaling pathways between retinal ganglion cells and glial cells. Exp Eye Res 2005; 81:207-17.
53. Ertel W, Keel M, Bonaccio M, Steckholzer U, Gallati H, Kenney JS, Trentz O. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma 1995; 39:879-85.
54. Shohami E, Bass R, Wallach D, Yamin A, Gallily R. Inhibition of tumor necrosis factor alpha (TNF-α) activity in rat brain is associated with cerebroprotection after closed head injury. J Cereb Blood Flow Metab 1996; 16:378-84.
55. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG, Hartl D, Yunis EJ, Goldfeld AE. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter. Tissue Antigens 1998; 52:359-67.
56. Hajeer AH, Hutchinson IV. Influence of TNF gene polymorphisms on TNF production and disease. Hum Immunol 2001; 62:1191-9.
57. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16:180-6.
58. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A. A common functional polymorphism (CA substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 1999; 8:1443-9.
59. Wang CY, Shen YC, Lo FY, Su CH, Lee SH, Lin KH, Tsai HY, Kuo NW, Fan SS. Polymorphism in the IL-1alpha (-889) locus associated with elevated risk of primary open angle glaucoma. Mol Vis 2006; 12:1380-5.
60. Lin HJ, Tsai SC, Tsai FJ, Chen WC, Tsai JJ, Hsu CD. Association of interleukin 1beta and receptor antagonist gene polymorphisms with primary open-angle glaucoma. Ophthalmologica 2003; 217:358-64.
61. Tsai FJ, Lin HJ, Chen WC, Chen HY, Fan SS. Insulin-like growth factor-II gene polymorphism is associated with primary open angle glaucoma. J Clin Lab Anal 2003; 17:259-63.